Ropharma Bras Market Cap ($29.58 Million)
Market Cap & Net Worth: Ropharma Bras (RPH)
Ropharma Bras market cap. Ropharma Bras (RO:RPH) has a market capitalization of $29.58 Million (RON128.84 Million) as of November 1, 2026. Listed on the RO stock exchange, this Romania-based company holds position #23644 globally and #46 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ropharma Bras's stock price RON0.25 by its total outstanding shares 511267413 (511.27 Million). Also see RPH cash generation efficiency for how efficiently the company converts equity into cash flow.
Ropharma Bras Market Cap History (2015–2026)
Ropharma Bras market cap history from 2015 to 2026. Data shows change from $40.27 Million to $29.58 Million (-2.49% CAGR). Check RPH share price today for real-time trading data and today's change.
Index Memberships
Ropharma Bras is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Bucharest Plus Index
BETPLUS
|
$69.11 Billion | 0.04% | #30 of 42 |
Weight: Ropharma Bras's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ropharma Bras Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ropharma Bras's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore RPH net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Ropharma Bras's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $24.42 Million | $717.81 Million | $6.75 Million | 0.03x | 3.62x |
| 2022 | $21.95 Million | $776.69 Million | $10.73 Million | 0.03x | 2.05x |
| 2023 | $23.48 Million | $912.74 Million | $9.22 Million | 0.03x | 2.55x |
| 2024 | $18.90 Million | $1.01 Billion | $7.72 Million | 0.02x | 2.45x |
| 2025 | $21.13 Million | $1.19 Billion | -$1.73 Million | 0.02x | N/A |
Competitor Companies of RPH by Market Capitalization
Companies near Ropharma Bras in the global market cap rankings as of November 1, 2026. Also see how large is Ropharma Bras's balance sheet for a full breakdown of the balance sheet.
Key companies related to Ropharma Bras by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1867 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2108 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2442 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3350 globally with a market cap of $5.22 Billion USD ( R$26.61 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1867 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.30 |
| #2108 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2442 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3350 | Raia Drogasil S.A | SA:RADL3 | $5.22 Billion | R$15.22 |
Market Capitalization of Ropharma Bras (2015–2026)
Market capitalization of Ropharma Bras from 2015 to today. Between 2015 and today, Ropharma Bras's market cap moved from $40.27 Million to $ 29.58 Million, with a yearly change of -2.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RON29.58 Million | +40.00% |
| 2025 | RON21.13 Million | +11.80% |
| 2024 | RON18.90 Million | -19.50% |
| 2023 | RON23.48 Million | +6.95% |
| 2022 | RON21.95 Million | -10.10% |
| 2021 | RON24.42 Million | -9.57% |
| 2020 | RON27.00 Million | -18.44% |
| 2019 | RON33.11 Million | -19.43% |
| 2018 | RON41.09 Million | -4.89% |
| 2017 | RON43.20 Million | +35.29% |
| 2016 | RON31.93 Million | -20.70% |
| 2015 | RON40.27 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Ropharma Bras was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.58 Million USD |
| MoneyControl | $29.58 Million USD |
| MarketWatch | $29.58 Million USD |
| marketcap.company | $29.58 Million USD |
| Reuters | $29.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ropharma Bras
S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, on… Read more